Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Vitasora Health (VHLUF) vs. Competitors

5 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
VHLUFVitasora Health$0.00$17.25M-1.90-3.33%―Unlock the VHLUF analyst price target with TipRanks PremiumVHLUFUnlock the VHLUF top-analyst price target with TipRanks Premium
AU:ONEOneview Healthcare Chess Depository Interests repr 1AUD 0.13AUD 104.90M-6.42-52.83%Moderate BuyUnlock the AU:ONE analyst price target with TipRanks PremiumVHLUF vs AU:ONEUnlock the AU:ONE top-analyst price target with TipRanks Premium
AU:M7TMach7 TechnologiesAUD 0.26AUD 61.10M-6.84-17.46%Moderate BuyUnlock the AU:M7T analyst price target with TipRanks PremiumVHLUF vs AU:M7TUnlock the AU:M7T top-analyst price target with TipRanks Premium
AU:BMTBeamtree Holdings LtdAUD 0.07AUD 20.08M-1.08-66.00%Moderate BuyUnlock the AU:BMT analyst price target with TipRanks PremiumVHLUF vs AU:BMTUnlock the AU:BMT top-analyst price target with TipRanks Premium
AU:ALCAlcidion Group LimitedAUD 1.20AUD 168.73M71.188.64%Moderate BuyUnlock the AU:ALC analyst price target with TipRanks PremiumVHLUF vs AU:ALCUnlock the AU:ALC top-analyst price target with TipRanks Premium
AU:PCKPainChek LtdAUD 0.07AUD 14.02M-1.54-84.42%―Unlock the AU:PCK analyst price target with TipRanks PremiumVHLUF vs AU:PCKUnlock the AU:PCK top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
VHLUFVitasora Health0.060.000.00%
AU:ONEOneview Healthcare Chess Depository Interests repr 10.13-0.16-56.90%
AU:M7TMach7 Technologies0.26-0.09-25.71%
AU:BMTBeamtree Holdings Ltd0.07-0.13-66.00%
AU:ALCAlcidion Group Limited1.200.2019.50%
AU:PCKPainChek Ltd0.07-0.33-83.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts